Added to YB: 2025-04-24
Pitch date: 2025-04-22
MEDP [neutral]
Medpace Holdings, Inc.
+90.56%
current return
Author Info
Compound & Fire shares at least one company deep dive every month. Sign up for the newsletter.
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
Market Cap
$15.4B
Pitch Price
$293.42
Price Target
N/A
Dividend
N/A
EV/EBITDA
26.28
P/E
38.18
EV/Sales
6.44
Sector
Life Sciences Tools and Services
Category
growth
Medpace Quick Scan – A Watchlist Star!
MEDP (watchlist): Top-tier clinical research organization with high Investment Readiness Score, strong fundamentals, impressive financials, solid backlog, low debt, and above-average growth. Market cap $8.96B, 30.5M shares, 24M float. Standout watchlist candidate for long-term investors.
Read full article (1 min)